Identification of a cellularly active SIRT6 allosteric activator
- 29 October 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Chemical Biology
- Vol. 14 (12), 1118-1126
- https://doi.org/10.1038/s41589-018-0150-0
Abstract
SIRT6, a member of the SIRT deacetylase family, is responsible for deacetylation of histone H3 Nε-acetyl-lysines 9 (H3K9ac) and 56 (H3K56ac). As a tumor suppressor, SIRT6 has frequently been found to have low expression in various cancers. Here, we report the identification of MDL-800, a selective SIRT6 activator. MDL-800 increased the deacetylase activity of SIRT6 by up to 22-fold via binding to an allosteric site; this interaction led to a global decrease in H3K9ac and H3K56ac levels in human hepatocellular carcinoma (HCC) cells. Consequently, MDL-800 inhibited the proliferation of HCC cells via SIRT6-driven cell-cycle arrest and was effective in a tumor xenograft model. Together, these data demonstrate that pharmacological activation of SIRT6 is a potential therapeutic approach for the treatment of HCC. MDL-800 is a first-in-class small-molecule cellular SIRT6 activator that can be used to physiologically and pathologically investigate the roles of SIRT6 deacetylation.Keywords
This publication has 52 references indexed in Scilit:
- SIRT6: Novel Mechanisms and Links to Aging and DiseaseTrends in Endocrinology & Metabolism, 2016
- SIRT6 Suppresses Pancreatic Cancer through Control of Lin28bCell, 2016
- The multifaceted functions of sirtuins in cancerNature Reviews Cancer, 2015
- SIRT6: A Promising Target for Cancer Prevention and TherapyAdvances in Experimental Medicine and Biology, 2014
- Chromatin and beyond: the multitasking roles for SIRT6Trends in Biochemical Sciences, 2014
- USP10 Antagonizes c-Myc Transcriptional Activation through SIRT6 Stabilization to Suppress Tumor FormationCell Reports, 2013
- Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patientsHepatology, 2013
- The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer MetabolismCell, 2012
- Sirtuin Catalysis and RegulationOnline Journal of Public Health Informatics, 2012
- Science of Cancer and AgingJournal of Clinical Oncology, 2007